Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 2 subfamily B member 11, or OR2B11, is a protein-coding gene encoding a seven-transmembrane G protein-coupled receptor (GPCR) expressed in the olfactory epithelium. Like other olfactory receptors, OR2B11 interacts with odorant molecules in the nasal cavity to initiate a neuronal response that triggers the perception of smell. These receptors share structural features with other GPCRs, notably a 7-transmembrane domain architecture, and are responsible for recognizing odorant signals and activating G protein-mediated signal transduction pathways. The olfactory receptor gene family, to which OR2B11 belongs, is the largest in the human genome. Although olfactory receptors have clear biological roles in sensory perception, and their activation mechanisms have been studied via molecular dynamics and structural biology methods, OR2B11 itself is not currently implicated in major disease mechanisms or used pharmacologically as a therapeutic target[3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 2 subfamily B member 11 (OR2B11).